Sigma Planning Corp’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,860
| Closed | -$256K | – | 1312 |
|
|
2025
Q1 | $256K | Sell |
35,860
-1,450
| -4% | -$10.4K | 0.01% | 1024 |
|
|
2024
Q4 | $288K | Sell |
37,310
-900
| -2% | -$6.96K | 0.01% | 944 |
|
|
2024
Q3 | $401K | Buy |
38,210
+5,701
| +18% | +$59.8K | 0.01% | 826 |
|
|
2024
Q2 | $380K | Buy |
32,509
+4,934
| +18% | +$57.7K | 0.01% | 833 |
|
|
2024
Q1 | $581K | Buy |
27,575
+15,145
| +122% | +$319K | 0.02% | 706 |
|
|
2023
Q4 | $223K | Sell |
12,430
-22,011
| -64% | -$395K | 0.02% | 740 |
|
|
2023
Q3 | $567K | Sell |
34,441
-15
| -0% | -$247 | 0.02% | 653 |
|
|
2023
Q2 | $689K | Buy |
34,456
+4,610
| +15% | +$92.2K | 0.02% | 606 |
|
|
2023
Q1 | $564K | Buy |
29,846
+7,175
| +32% | +$136K | 0.02% | 748 |
|
|
2022
Q4 | $514K | Sell |
22,671
-107
| -0.5% | -$2.43K | 0.02% | 753 |
|
|
2022
Q3 | $602K | Sell |
22,778
-2,070
| -8% | -$54.7K | 0.02% | 659 |
|
|
2022
Q2 | $614K | Buy |
24,848
+177
| +0.7% | +$4.37K | 0.02% | 672 |
|
|
2022
Q1 | $819K | Sell |
24,671
-25
| -0.1% | -$830 | 0.02% | 621 |
|
|
2021
Q4 | $808K | Sell |
24,696
-117
| -0.5% | -$3.83K | 0.02% | 626 |
|
|
2021
Q3 | $1.04M | Buy |
24,813
+906
| +4% | +$38K | 0.03% | 523 |
|
|
2021
Q2 | $929K | Buy |
23,907
+142
| +0.6% | +$5.52K | 0.03% | 576 |
|
|
2021
Q1 | $811K | Buy |
+23,765
| New | +$811K | 0.03% | 577 |
|
|
2018
Q3 | – | Sell |
-3,180
| Closed | -$228K | – | 967 |
|
|
2018
Q2 | $228K | Buy |
+3,180
| New | +$228K | 0.02% | 772 |
|